Cargando…

Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer’s Disease

Alzheimer’s disease (AD) is the leading cause of dementia that has remained a major medical, sociocultural and economical challenge globally. Previously developed treatments like anticholinesterase inhibitors (AChEIs) and N-methyl-D-aspartate receptor (NMDAR) antagonists only provide short-term symp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abyadeh, Morteza, Gupta, Vivek, Gupta, Veer, Chitranshi, Nitin, Wu, Yunqi, Amirkhani, Ardeshir, Meyfour, Anna, Sheriff, Samran, Shen, Ting, Dhiman, Kunal, Salekdeh, Ghasem H., Haynes, Paul A., Graham, Stuart L., Mirzaei, Mehdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JKL International LLC 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612603/ https://www.ncbi.nlm.nih.gov/pubmed/34881080 http://dx.doi.org/10.14336/AD.2021.0719

Ejemplares similares

Apolipoprotein ε in Brain and Retinal Neurodegenerative Diseases
por: Abyadeh, Morteza, et al.
Publicado: (2023)

Key Genes and Biochemical Networks in Various Brain Regions Affected in Alzheimer’s Disease
por: Abyadeh, Morteza, et al.
Publicado: (2022)

A Proteomic View of Cellular and Molecular Effects of Cannabis
por: Abyadeh, Morteza, et al.
Publicado: (2021)

Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers
por: Abyadeh, Morteza, et al.
Publicado: (2020)

Oxidative Stress Induced Dysfunction of Protein Synthesis in 661W Mice Photoreceptor Cells
por: Deng, Liting, et al.
Publicado: (2023)

The Dynamic Proteome of Oligodendrocyte Lineage Differentiation Features Planar Cell Polarity and Macroautophagy Pathways
por: Pooyan, Paria, et al.
Publicado: (2020)

Amyloid β Induces Early Changes in the Ribosomal Machinery, Cytoskeletal Organization and Oxidative Phosphorylation in Retinal Photoreceptor Cells
por: Deng, Liting, et al.
Publicado: (2019)

Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer’s Disease: Computational Refining and Biochemical Evaluation
por: Chitranshi, Nitin, et al.
Publicado: (2021)

Retinal thickness and vascular parameters using optical coherence tomography in Alzheimer’s disease: a meta-analysis
por: Sheriff, Samran, et al.
Publicado: (2023)

Fingolimod effects on the brain are mediated through biochemical modulation of bioenergetics, autophagy, and neuroinflammatory networks
por: Mirzaei, Mehdi, et al.
Publicado: (2022)

Amyloid-beta peptide neurotoxicity in human neuronal cells is associated with modulation of insulin-like growth factor transport, lysosomal machinery and extracellular matrix receptor interactions
por: Deng, Liting, et al.
Publicado: (2020)

Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner
por: Abbasi, Mojdeh, et al.
Publicado: (2021)

Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell–cell interactions in the pathophysiology of neurological disease
por: Godinez, Angela, et al.
Publicado: (2022)

Evaluating associations of RNFL thickness and multifocal VEP with cognitive assessment and brain MRI volumes in older adults: Optic nerve decline and cognitive change (ONDCC) initiative
por: Shen, Ting, et al.
Publicado: (2022)

Proteome-Wide Profiling Using Sample Multiplexing of a Human Cell Line Treated with Cannabidiol (CBD) and Tetrahydrocannabinol (THC)
por: Abyadeh, Morteza, et al.
Publicado: (2023)

Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes
por: Mirzaei, Mehdi, et al.
Publicado: (2017)

Safety, Tolerability, and Pharmacokinetics of Zagotenemab in Participants with Symptomatic Alzheimer’s Disease: A Phase I Clinical Trial
por: Willis, Brian A., et al.
Publicado: (2023)

Molecular determinants and interaction data of cyclic peptide inhibitor with the extracellular domain of TrkB receptor
por: Chitranshi, Nitin, et al.
Publicado: (2016)

Aducanumab for Alzheimer’s disease?
por: Walsh, Sebastian, et al.
Publicado: (2021)

Neuroprotective Effects of Neuropeptide Y on Human Neuroblastoma SH-SY5Y Cells in Glutamate Excitotoxicity and ER Stress Conditions
por: Palanivel, Viswanthram, et al.
Publicado: (2022)

Glaucoma is associated with plasmin proteolytic activation mediated through oxidative inactivation of neuroserpin
por: Gupta, Vivek, et al.
Publicado: (2017)

Correction to: Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement
por: Sharma, Samridhi, et al.
Publicado: (2022)

Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement
por: Sharma, Samridhi, et al.
Publicado: (2022)

Aducanumab: What about the Patient?
por: Petersen, Ronald C.
Publicado: (2021)

Is Aducanumab for LMICs? Promises and Challenges
por: Gunawardena, Illangage P. C., et al.
Publicado: (2021)

Aducanumab: Appropriate use recommendations
por: Cummings, Jeffrey, et al.
Publicado: (2021)

Aducanumab: Appropriate Use Recommendations
por: Cummings, J., et al.
Publicado: (2021)

Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL(pro) targeting repurposed drug candidates
por: Chitranshi, Nitin, et al.
Publicado: (2020)

Cell Cycle Deficits in Neurodegenerative Disorders: Uncovering Molecular Mechanisms to Drive Innovative Therapeutic Development
por: Joseph, Chitra, et al.
Publicado: (2020)

Anti-inflammatory Effects of Siponimod in a Mouse Model of Excitotoxicity-Induced Retinal Injury
por: Basavarajappa, Devaraj, et al.
Publicado: (2023)

The Association of APOE ε4 Allele with Retinal Layer Thickness and Microvasculature in Older Adults: Optic Nerve Decline and Cognitive Change Study
por: Sheriff, Samran, et al.
Publicado: (2023)

Aducanumab: Appropriate Use Recommendations Update
por: Cummings, J., et al.
Publicado: (2022)

Practical Considerations in the Administration of Aducanumab for the Neurologist
por: Coerver, Katherine, et al.
Publicado: (2022)

Aducanumab—Hope or Disappointment for Alzheimer’s Disease
por: Wojtunik-Kulesza, Karolina, et al.
Publicado: (2023)

An insider's perspective on FDA approval of aducanumab
por: Wang, Yaning
Publicado: (2023)

Aducanumab as a Novel Treatment for Alzheimer’s Disease: A Decade of Hope, Controversies, and the Future
por: Esang, Michael, et al.
Publicado: (2021)

Pre-Treatment of Rice Plants with ABA Makes Them More Tolerant to Multiple Abiotic Stress
por: Habibpourmehraban, Fatemeh, et al.
Publicado: (2023)

Regulation of Brain-Derived Neurotrophic Factor and Growth Factor Signaling Pathways by Tyrosine Phosphatase Shp2 in the Retina: A Brief Review
por: Abbasi, Mojdeh, et al.
Publicado: (2018)

Y chromosome is moving out of sex determination shadow
por: Heydari, Raheleh, et al.
Publicado: (2022)

Topical Insights Into the Post-Approval Controversies of Aducanumab
por: Kumar, Dhiraj, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g26oibgjj3c01h153p4q3qai9n